Company
Imperative Care
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
18
510(k), De Novo and PMA
Device trials
4
As lead sponsor, any status
Adverse event reports
49
Received Nov 1, 2025 to Nov 20, 2026
Recall records
1
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.
Total raised (reported)
$530M
5 Form D offerings, 2019 to 2026
Equity
$419M
Stock sold for cash
Debt and convertible notes
$111M
$111M of it convertible
Last known valuation
Unknown
Form D filings do not report valuation
Latest round: convertible note, $111M raised of $111M sought, first sale Mar 13, 2026, 15 investors.
Funding rounds (Form D)
One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.
| First sale | Type | Raised | Round size | Investors | Exemption and agent | Filing |
|---|---|---|---|---|---|---|
| Mar 13, 2026 | Convertible note | $111M | $111M | 15 | Rule 506(b) | Form D/A ↗Jul 10, 20261 amendment |
| Jul 23, 2024 | Equity | $72.6M | $150M | 19 | Rule 506(b) | Form D ↗Jul 31, 2024 |
| Jul 14, 2021 | Equity | $260M | $261M | 12 | Rule 506(b) | Form D ↗Jul 22, 2021 |
2 more funding rounds with a free account
Company details
From the company's latest Form D.
- Legal name
- Imperative Care, Inc.
- Headquarters
- Campbell, California
- Incorporated
- Delaware over five years before filing
- Entity type
- Corporation
- Revenue range
- Decline to Disclose
- Industry filed under
- Other Health Care
- SEC filer
- CIK 1668962 ↗
Executives, directors and promoters
As listed on the latest Form D.
17 more people on the filing with a free account
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Imperative Care.
Latest FDA decisions
The 8 newest of 18 since 2015.
- Zoom 4S Catheter510(k)
K261176 · Decided Aug 28, 2026 · 140 days after receipt
Device type: Catheter, Percutaneous, Neurovasculature (QJP) · Cardiology
K252046 · Decided Oct 30, 2025 · 122 days after receipt
Device type: Catheter, Thrombus Retriever (NRY) · Cardiology
K252057 · Decided Aug 28, 2025 · 58 days after receipt
Device type: Peripheral Mechanical Thrombectomy With Aspiration (QEW) · Cardiology
15 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
NCT07491952 · 750 participants (planned) · Start Mar 24, 2026 · Primary completion Mar 31, 2030
Device: Zoom System · For: Ischemic Stroke; Acute Stroke
Sites: Huntsville, Alabama; Walnut Creek, California; Tampa, Florida · 26 sites in all
NCT07350499 · 750 participants (planned) · Start Feb 13, 2026 · Primary completion Mar 2030
Device: Prodigy Thrombectomy System; Symphony Thrombectomy System and 1 more · For: Arterial Thromboembolism; Venous Thromboembolism; Pulmonary Embolism
Sites: Huntsville, Alabama; Clearwater, Florida; Jacksonville, Florida · 13 sites in all
NCT06062329 · 110 participants · Start Dec 13, 2023 · Primary completion May 4, 2025
Device: Symphony Thrombectomy System · For: Acute Pulmonary Embolism; Thromboembolism; Emboli, Pulmonary and 5 more
Sites: Huntsville, Alabama; Los Angeles, California; Jacksonville, Florida · 19 sites in all
1 more trials with a free account
Reports received
49
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
16
33% of reports
Injury reports
24
49% of reports
Death reports
9
18% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 3 | 0 | 0 |
| Jan 24 | 0 | 1 | 0 | 0 |
| Feb 24 | 3 | 7 | 0 | 0 |
| Mar 24 | 0 | 0 | 1 | 0 |
| Apr 24 | 2 | 3 | 0 | 0 |
| May 24 | 1 | 1 | 0 | 0 |
| Jun 24 | 1 | 0 | 1 | 0 |
| Jul 24 | 2 | 2 | 4 | 0 |
| Aug 24 | 0 | 3 | 2 | 0 |
| Sep 24 | 1 | 1 | 0 | 0 |
| Oct 24 | 1 | 1 | 0 | 0 |
| Nov 24 | 0 | 4 | 1 | 0 |
| Dec 24 | 1 | 0 | 0 | 0 |
| Jan 25 | 1 | 1 | 0 | 0 |
| Feb 25 | 2 | 1 | 0 | 0 |
| Mar 25 | 1 | 0 | 0 | 0 |
| Apr 25 | 2 | 3 | 0 | 0 |
| May 25 | 0 | 3 | 0 | 0 |
| Jun 25 | 1 | 3 | 0 | 0 |
| Jul 25 | 0 | 5 | 0 | 0 |
| Aug 25 | 0 | 2 | 0 | 0 |
| Sep 25 | 1 | 2 | 0 | 0 |
| Oct 25 | 1 | 3 | 0 | 0 |
| Nov 25 | 0 | 2 | 0 | 0 |
| Dec 25 | 0 | 10 | 0 | 0 |
| Jan 26 | 2 | 1 | 1 | 0 |
| Feb 26 | 1 | 0 | 2 | 0 |
| Mar 26 | 2 | 1 | 0 | 0 |
| Apr 26 | 3 | 0 | 0 | 0 |
| May 26 | 6 | 1 | 0 | 0 |
| Jun 26 | 0 | 4 | 1 | 0 |
| Jul 26 | 1 | 1 | 1 | 0 |
| Aug 26 | 0 | 2 | 3 | 0 |
| Sep 26 | 0 | 1 | 0 | 0 |
| Oct 26 | 1 | 1 | 1 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
5 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2577-2021 · Started Aug 13, 2021 · Posted by FDA Sep 29, 2021
Reason given: There is a potential for distal end of catheters to fracture and become detached.
Cause as FDA categorized it: Under Investigation by firm · Device type: Catheter, Thrombus Retriever (NRY)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.